


Diversified Consumer Services | Small Cap
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Nidan Laboratories & Healthcare Ltd demonstrates a mixed financial performance. The company exhibits strong solvency and profitability, suggesting a solid foundation. Its liquidity position is also reasonably good, indicating the company's ability to meet its short-term obligations. However, growth metrics and financial ratios reveal causes for concern, highlighting potential challenges in revenue and earnings sustainability. The company's efficiency needs improvement, particularly in fixed asset and capital turnover. While the company shows strengths in managing debt and generating profits, addressing the identified weaknesses is crucial for ensuring long-term financial health and stability.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
12.92
Industry Median
49.41
Small Cap Median
46.45
P/E RATIO
12.80
P/B RATIO
0.28
Industry Median
4.69
Small Cap Median
3.77
P/S RATIO
0.76
Industry Median
3.90
Small Cap Median
2.20
Others
PEG RATIO
0.00
EV/EBITDA RATIO
3.36
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹13.95 as on Jul 13, 2026.
The growth ratios present a mixed picture of the company's performance. Revenue and asset growth is encouraging, suggesting expansion in operations and asset base. However, the negative Operating Profit Growth Rate, EPS Growth, and Net Income Growth Rate raise concerns about the sustainability of earnings. While the company is growing, its profitability is declining, which needs to be addressed for long-term viability.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 45.53 | -18.17 | -0.37 | 1.45 | 4.12 |
| Operating Profit Growth Rate | 5.85 | -27.74 | -5.29 | -21.43 | -4.35 |
| Earnings Per Share (EPS) Growth | -17.67 | 33.51 | -190.98 | -161.21 | -23.24 |
| Asset Growth Rate | 64.64 | -4.61 | -2.19 | 0.47 | 1.28 |
| Net Income Growth Rate | 15.65 | 33.08 | -191.24 | -161.3 | -23.74 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Nidan Laboratories & Healthcare Ltd | 6.32 | 12.80 | Neutral | 4.84 | 1.08 | 1.51 |
| 2 | Aatmaj Healthcare Ltd | 6.29 | 63.87 | Undervalued | 2.36 | 0.32 | 0.71 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Concall Report⬤3rd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Annual Report⬤2nd Jul 26
Annual Report 2025-26
UNDEFINED SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT
Concall Report⬤2nd Jul 26
Q4 FY26 Earnings Conference Call
BULLISH SENTIMENT